Scinai Immunotherapeutics Ltd. Sponsored ADR SCNI 深 沪
已收盘 04-02 16:00:00 美东时间
0.60
-0.039
-6.12%
华盛通- 最 高0.62
- 今 开0.62
- 成交量 3.72万股
- 最 低 0.5713
- 昨 收 0.6391
- 总市值 212.13万
- 52周最高 6.18
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.55
- 委 比 78.57%
- 总股本 353.55万
- 历史最高 6200.00
- 量 比 0.24
- 振 幅 7.62%
- 历史最低 0.55
- 每 手 1
- 风险率 0.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Scinai Immunotherapeutics shares are trading higher after the company reported a year-over-year increase in FY sales results.
Scinai Immunotherapeutics shares are trading higher after the company reported ...
04-01 23:34
Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY
Scinai Immunotherapeutics (NASDAQ:SCNI) reported quarterly losses of $(3.56) per share. The company reported $1.311 million in sales this quarter. This is a 99.24 percent increase over sales of $658.000 thousand the
04-01 20:09
Scinai Immunotherapeutics Receives Non-Compliance Notification From Nasdaq
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) ("Scinai" or the "Company"), today announced that it received a written notification from the Nasdaq Listing Qualifications Department on March 12, 2026 indicating that
03-17 04:14
Scinai Executes Second Amendment To Binding Option Agreement For Acquisition Of PinCell And Submits Revised Application Under European FENG SMART Path Program
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI);("Scinai" or the "Company"), today announced the execution of a Second Amendment to its Binding Option Agreement for the acquisition of PinCell S.r.l., and the submission
03-02 22:22
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
Scinai Immunotherapeutics ( ($SCNI) ) has issued an announcement. On October 6,...
2025-10-06 20:20
Scinai Immunotherapeutic Awarded Grant Of About $246K From Israel Innovation Authority To Finance Project To Acquire, Install Fill-And-finish System For Sterile Manufacturing
Grant funds two-thirds of a NIS 1.23 million ($373K) project to strengthen Scinai Bioservices' small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies in Israel and
2025-10-06 19:38
Scinai Immunotherapeutics reports 1H results
Scinai Immunotherapeutics press release (NASDAQ:SCNI): 1H Revenue of $0.77M. Net loss was $4,134 thousand, compared to $4,481 thousand in the six months ended June 30, 2024, reflecting higher revenues...
2025-09-02 20:58
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Celestica Inc. (NYSE:CLS) rose sharply in pre-market trading after th...
2025-07-29 18:46
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 24.9% to $3.11 duri...
2025-07-02 20:06
Scinai Immunotherapeutics shares are trading higher after the company announced that it was granted clearance under the Golden Power regulation for Scinai's option to acquire 100% of the share capital and voting rights of Pincell.
Scinai Immunotherapeutics shares are trading higher after the company announced...
2025-06-05 22:37
